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Background: Metastatic lesions localized in the periacetabular area cause troublesome pain and reduced mobility
of the patients. Radiotherapy effectively decreases pain, yet it does not restore the ability to load the joint. Surgical
treatment involving resection of metastatic lesions and joint reconstruction using bone grafts is burdened with a
high rate of complications. Modular tumor prostheses are being increasingly used. In some cases, it is possible to
strengthen the acetabular roof with bone cement using vertebroplasty kits. The aim of the study was to
demonstrate various methods of treatment of metastatic lesions localized in the periacetabular area together with
the analysis of their results and effectiveness.
Methods: Between 2010 and 2015, 27 patients with cancer metastases to the acetabulum were treated at our
department. Qualification for surgical treatment was multifaceted with numerous aspects being considered. They
included patients’ general condition, type of neoplasm, clinical stage, and prognosis. CT and MRI scans of the pelvis
were performed in each case. Before the surgery and 3 months following the surgery, visual analogue scale (VAS)
pain intensity, Karnofsky functional status, and motor ability according to the Harris scale were evaluated. Bone
cement (PMMA)-augmentation was performed in 21 patients, of whom nine had cement injected precutaneously
and 12 at proximal femur resection alloplasty. Hemipelvectomy Type II combined with implantation of LUMiC
resection prosthesis of the acetabulum were performed in six cases.
Results: The quality of life improved in all the patients. After percutaneous cement injection, the mean pain
intensity VAS score was 2.7, and the mean Karnofsky functional status score was 71.8. The mean postoperative
Harris hip score (HHS) was 94 points. The patients who had undergone resection alloplasty on the proximal femur
combined with periacetabular cement injection were walking using one crutch. In this group of patients, the mean
postoperative pain intensity, functional status, and gait efficiency scores were 4.5, 65.7, and 82 points, respectively.
The mean pain intensity VAS score in patients who had LUMiC prostheses implanted was 3.4. Their mean functional
status score was 65 and the gait efficiency score 71 points. All the patients were able to walk on crutches.
Conclusions: Strengthening of the acetabular roof with bone cement in a specific group of patients is an adequate
method of treatment which decreases pain and allows for loading the affected limb while walking. Internal
hemipelvectomy combined with LUMiC prosthesis implantation makes it possible for the patients to walk using
crutches and significantly reduces pain.
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Background
Bone metastatic lesions concern between 30 and 70 % of
patients. The sites most commonly affected are the
spine, the pelvic bones, and the proximal part of the
femur and the humerus. Lytic and mixed metastases
may cause tormenting pain, reduced mobility, and
pathological fractures. Massive metastases to the pelvis,
especially to the periacetabular area, are still a difficult
treatment problem. They inhibit patients’ walking inde-
pendently, thus forcing necessity to use crutches or a
walking frame. Joint motion is usually significantly lim-
ited and related to pain. These infirmities are accompan-
ied by imminent muscle atrophy. Bed-ridden patients
are more likely to develop thromboembolism and infec-
tious complications. The patients need constant care of
the family or healthcare practitioners and require anal-
gesic treatment [1–3].
Until recently, the treatment of metastatic lesions lo-
calized in the pelvis was limited to radiotherapy which
effectively decreased pain but did not restore the ability
to load the affected joint [2].
Treatment planning requires an in-depth analysis of
patient’s general condition, stage of cancer, and prog-
nosis. Qualification must be multifaceted and multi-
disciplinary. It is necessary to perform CT and MRI
so as to carefully examine the extent of the lesions,
infiltration of muscles, vessels, and nerves, and to
plan bone reconstruction. The use of massive bone
grafts to reconstruct losses in the acetabular area is
controversial, because of high risk of infections and
bone healing problems. Specially designed modular
prostheses, the acetabular part of which is seated in
the iliac ala or even in the lumbar vertebra, are being
increasingly used. In the case of minor lytic lesions
when the cortical bone is undamaged, it is a good so-
lution to perform PMMA-augmentation with the use
of vertebroplasty kits. Bone cement increases the re-
sistance of the acetabulum and allows full loading of
the affected limb. In some cases, it is possible to seat
the acetabular part of the hip prosthesis without the
need for complicated reconstructions [4–10].
Aim of the study
The aim of this study was to demonstrate various
methods of treatment of tumor-induced losses localized
in the periacetabular area together with the analysis of
their results and effectiveness.
Methods
Between 2010 and 2015, 27 patients with cancer metastases
to the acetabulum were treated at the orthopedic oncology
department in Brzozów. The following aspects were ana-
lyzed in the qualification for the treatment: patient’s general
condition, type of cancer, clinical stage of cancer, and prog-
nosis. Each time, CT and MRI were carried out prior to the
surgery. What were analyzed were the extension of bone
losses, the cortical bone condition, and the possibility of hip
replacement. Before the surgery and 3 months following the
surgery, visual analogue scale (VAS) pain intensity, Kar-
nofsky functional status, and motor ability according to the
Harris scale were evaluated. The analysis covered the course
of the surgery and the perioperative period and complica-
tions and their causes. Follow-up radiographs were per-
formed on postoperative day 1 and then on a 6-week basis.
Careful attention was given to whether there were symp-
toms of local recurrence of the neoplastic disease, new foci
of the disease, damage to implants, or their loosening.
Bone cement (PMMA) augmentation was performed in
21 patients, of whom nine had cement injected precuta-
neously (Figs. 1 and 2), while 12 patients required prox-
imal femur resection alloplasty, in which case the cement
was injected using an open surgery method (Fig. 3). Each
time, a full volume of 10 ml of bone cement was given in
a single injection to prevent leakage. The cement was in-
fused within approximately 5 min using titration method,
several times changing the position of a needle in the hip
bone. Metastatic tumor was resected in six patients (hemi-
pelvectomy type II), and a LUMiC resection prosthesis of
the acetabulum was implanted (Figs. 4 and 5). Two pros-
theses were implanted without cement, while four pros-
theses were implanted using vacuum-mixed bone cement
injected with a positive pressure.
Fig. 1 Anteroposterior radiogram (a) and transverse CT scan (b) in a kidney cancer patient with lytic bone loss in the right periacetabular area.
Follow-up radiogram after bone cement (PMMA) augmentation (c)
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Three weeks after the surgery, all the patients were sub-
jected to a single radiation dose of 8 Gy. The observation
period lasted between 4 and 49 months (mean 16 months).
The majority of the treated patients (18) were women.
There were nine men. The mean age was 63 for women
(range 42–81) and 68 for men (range 54–82).
In our study, the most common cause of the destruction
of the acetabulum was a metastasis from breast cancer (11
patients), followed by multiple myeloma (seven patients),
kidney cancer (six patients), and lung cancer (three
patients). The mean time interval between the diagnosis of
cancer and the occurrence of a metastasis was 22 months.
The research has been performed in accordance with
the declaration of Helsinki. As this retrospective analysis
consists of anonymised clinical routine data, the Research
Ethics Committee (Okręgowa Izba Lekarska in Crakov,
ul Krupnicza, 11a 31-123) deems the application for and
issue of an Ethics approval not necessary. All the patients
gave a written consent to the use of data for research.
Results
The patients who had undergone resection alloplasty on
the proximal femur combined with acetabular cementation
were walking with one crutch. The pain they experienced
did not increase when loading the operated limb. In this
group of patients, the mean preoperative and postoperative
VAS pain intensity scores were 8.2 and 4.5, respectively.
The mean Karnofsky functional status score was 47.2 be-
fore the surgery and 65.7 after the operation. The postoper-
ative gait efficiency score (HHS) was 82 points.
In the group of patients with LUMiC prostheses, the
mean preoperative VAS pain intensity score was 8.1 and
the mean preoperative Karnofsky functional status score
was 40.2. The following mean scores were recorded after
the surgery: VAS 3.4, Karnofsky 65, HHS 71 (Table 1).
All the surgically treated patients reported improvement
in the quality of life after the operation. Three patients
were walking on one crutch, two of them were using two
crutches, and one patient was walking unaided.
A decrease in the strength of muscles in the operated
limb was noted after implantation of both LUMiC and
proximal femur prostheses. Trendelenburg’s sign was
positive, which was indicative of gluteal muscle dysfunc-
tion. Eight patients were able to manage the stairs alter-
nating feet, while ten patients were reverting to each
step. Until the present day, pathological fractures or
local recurrences in the proximity of the operated joint
have not been detected. Persisting serous discharge from
a surgical wound was noted in one patient after LUMiC
prosthesis implantation. Within 3 weeks, the wound
healed after antibiotic treatment and there was no need
for surgical management. No thromboembolic complica-
tions, damage to implants, or dislocation of prostheses
were observed. Limb length discrepancy ranging from 1
to 4 cm (mean 2 cm) was not particularly troublesome.
It was compensated using insoles for shoes.
Results of the treatment of bone losses in the pelvis with
bone cement (PMMA) using vertebroplasty kits are very
encouraging. No inflammatory reactions in soft tissues after
precutaneous injection of cement were noted. Follow-up
radiographic results using this method were found satisfac-
tory. No significant degrees of leakage of bone cement into
the muscles or the hip joint were observed. Further radio-
grams did not reveal osteolysis in the area of bone cement,
bone cement dislocation, or loosening within the hip bone.
No fractures within the strengthened acetabulum were
noted in any of the patients. The quality of life improved in
all the patients as a result of reduced pain or its complete
regression. The mean VAS pain intensity score in patients
undergoing isolated acetabular cementation was 6.9 before
the surgery and 2.7 after the operation. The mean
Fig. 2 Anteroposterior radiogram (a) with lytic bone loss in the right
periacetabular area and radiogram after bone cement (PMMA)
augmentation (b)
Fig. 3 Anteroposterior radiogram of the pelvis in a patient with
breast cancer metastasis to the proximal femur and the acetabulum
(a). Postoperative radiogram (b). Visible resection prosthesis of the
hip joint and methacrylate (PMMA) that was used for reconstruction
of bone loss in the acetabulum
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Karnofsky functional status score was 52.5 before the sur-
gery and 71.8 after the procedure. The mean postoperative
Harris hip score (HHS) was 94 points. All the patients were
walking unaided; loading the operated limb did not cause
pain.
Discussion
The treatment for metastatic lesions localized in the
periacetabular area depends on the patient’s general con-
dition, prognosis, and the extension and localization of
the lesion [11, 12].
Non-surgical treatment is employed in patients in a poor
general state of health who are not considered for surgery
and in patients with a tumor localized in zones I and III
according to the Enneking and Dunham classification.
Radiotherapy is the most frequent method of treatment
that reduces pain and rate of local recurrence. Radiotherapy
is also used as adjuvant therapy after surgery. Embolization,
which reduces tumor size and vascularization and causes
tumor calcification, is another increasingly used method. Its
analgesic effect lasts for half a year. Preoperative
embolization reduces intraoperative bleeding, allows for a
precise tumor dissection, and shortens the time of surgery.
Preoperative embolization is particularly indicated for pa-
tients with hypervascular tumors (renal and thyroid
metastases).
In the treatment of prostate and breast cancers and
myeloma, multiplex bisphosphonates are used. They are
effective in reducing pain and the number of subsequent
fractures.
Other less common treatment methods include elec-
trochemotherapy, radiofrequency ablation, and thermo-
therapy [13].
Surgical treatment most often is required in patients with
tumor localized in zone II according to the Enneking and
Dunham classification. Wide resection is used in patients
with an extensive bone loss and in solitary bone metastasis,
especially from breast, thyroid, and kidney cancers. Intrale-
sional resection is performed in patients with diffuse pelvic
involvement when wide resection is not possible. Ruggieri
et al. have not demonstrated any statistically significant dif-
ferences in the survival to death and survival to local recur-
rence between the patients after wide resection and the
patients after intralesional resection [14].
There are many ways of pelvic bone losses reconstruc-
tion which aim at achieving a good functional treatment
outcome. The indications for different treatment
methods depend on patient’s prognosis, tumor location
and size, and experience and preferences of the surgeon.
In the case of pelvic bone losses due to cancer, the use
of massive bone grafts is debatable as burdened with a
high risk of infectious complications and healing disor-
ders. The patients are forced to unload the operated
limb. For that reason, modular or custom-made pros-
theses are being increasingly used.
Stem acetabular prostheses are particularly often used
in patients with a good prognosis and solitary bone
Fig. 4 Preoperative (a) and postoperative radiogram (b) in a patient after resection of a metastatic tumor in the pelvis. Internal hemipelvectomy
type II was performed (the size of metastasis and the extension of the resection of the hip bone was marked with a highlighter); a LUMiC
prosthesis was implanted with the use of cement. A standard stem of hip prosthesis was implanted after resection of a metastasis localized in the
neck of the femur
Fig. 5 Preoperative radiogram of a metastatic tumor in the pelvis (a)
and after LUMiC endoprosthesis implantation (b)
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metastases. Patients in IV class according to the Harrin-
gton classification are candidates for this procedure. It is
a relatively simple surgical technique, but instability or
dislocation of a prosthesis may occur [11, 12, 15, 16].
In the Harrington I class, total hip replacement with
or without acetabular support rings has been described.
Very extensive bone loss requires custom-made endo-
prosthetic replacement.
The Harrington technique of pelvic bone loss recon-
struction requires a wide surgical approach and is asso-
ciated with the risk of complications; however, it
guarantees a good functional outcome. It is particularly
often applied in patients in Harrington III class [11, 12].
The injection of cement under pressure using ver-
tebroplasty kits is to a certain extent a novelty. This
method was applied and described by Georgy in 2009.
He operated on 12 patients with lytic metastases to
the hip bone and assessed the gait efficiency as well
as the VAS pain intensity. The results were good. The
mean preoperative VAS score was 8.6, while the mean
postoperative VAS score was 3.8 [16]. Good treatment
results were also accomplished by Hierholzer et al.
and Yong-il Kim et al. [17, 18]. Maccauro et al. per-
formed acetabuloplasty in 25 patients, five of whom
underwent bilateral surgery. He did not observe any ser-
ious complications; symptoms of vein thrombosis oc-
curred in two patients. Complete pain regression was
recorded in the majority of patients [19].
Weil et al. succeeded in achieving positive results as
regards pain which was reduced or erased in 83 % of
cases in the group of 18 patients who had undergone re-
constructive operation with the use of cement. The pa-
tients were able to walk unaided without taking
analgesics [10].
The LUMiC prosthesis was designed to treat bone
damage that occurs during the course of the neoplastic
disease in the periacetabular area. The classical method
involves prosthetic implantation with no cement used.
The specially shaped stem has the purpose of minimiz-
ing the rotating motion of the prosthesis in relation to
bones. The surface of the prosthesis allows for growing
of bones into it and secondary stabilization. It is also
agreed to implant the acetabulum using bone cement,
which ensures the primary stability of the prosthesis and
facilitates immediate limb loading [5, 20, 21].
As Capanna et al. see it, prosthetic implantation
after resection of cancer metastases to bones can be
performed with the use of cement which enables im-
mediate and full limb loading. The additional merit of
this method is that it reduces the risk of implant loos-
ening after radiotherapy [22, 23].
Similarly, Hoffmann et al., Grosheger et al., and
Gebert et al. studies have demonstrated that the re-
sults of the treatment of bone metastases using
cement-retained prostheses are good. The risk of their
loosening in consequence of radiotherapy is low, and
the incidence of infectious complications is similar
when cement is not used. The patients can start
walking, fully loading the operated limb immediately
after the surgery. In the case of cement-free pros-
theses, full limb loading is recommended only after
6–12 weeks following the surgery [24–26].
Some researches have shown a low rate of infec-
tious complications (5.4–7.9 %) and aseptic loosening
(5.4–8,7 %) among patients who had cement-retained
prostheses implanted [23].
Saddle prostheses have failed to meet the hopes they
evoked. They loosened quickly or were primarily un-
stable. The incidence of dislocation was high; they also
caused troublesome pain. Hip joint motion and the func-
tion of the limb were limited [27]. Wedemayer and
Kauther point out that functional results are unsatisfac-
tory in patients with saddle prostheses. In 70 % of the
cases, trouble walking even on both crutches was
reported [28].
Wang et al. succeeded in achieving satisfactory func-
tional results evaluated by MSTS in the group of 50 pa-
tients who had tumor prostheses implanted after resection
of pelvic tumors. Despite that the center of joint rotation
was moved superiorly and medially, the function of gluteal
muscles was proper enough to allow good performance in
walking. In 80 % of the cases, no symptoms of loosening
were detected 3 years after the surgery [8].
In our study group, six patients with LUMiC prostheses
reported significant pain relief and their functional status
improved. A large decrease in the strength of gluteal mus-
cles was not perceived as particularly troublesome by the
patients. No infectious complications, loosening and dis-
location of implants, or local recurrences of the neoplastic
disease were noted.
Table 1 The table presents the mean pain intensity, functional status, and gait efficiency scores in pre- and postoperative periods
Type of surgery VAS VAS Karnofsky Karnofsky HHS
Before the surgery After the surgery Before the surgery After the surgery After the surgery
PMMA 6.9 2.7 52.5 71.8 94
PMMA + PFE 8.2 4.5 47.2 65.7 82
LUMiC 8.1 3.4 40.2 65 71
Abbreviations: PMMA bone cement, PFE proximal femur endoprosthesis
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The patients who had undergone cement augmenta-
tion appreciated a significant improvement in the quality
of life. The pain significantly decreased, and the func-
tional status improved. All the patients were able to walk
unaided, fully loading the operated limb.
Patients qualified for cement augmentation of the
periacetabular area should be those with without
very extensive bone losses and undamaged cortical
layers which allows injecting cement under positive
pressure. A correct titration cementing technique re-
ducing the risk of uncontrollable leakage is of im-
portance [29].
Conclusions
1. Augmentation of tumor-induced losses in the peria-
cetabular area is an adequate method of treatment
which decreases pain and allows for loading the
affected limb while walking.
2. A condition necessary for qualification for the bone
cement augmentation is undamaged cortical bone
layer which enables injecting cement under positive
pressure and prevents its leakage.
3. The LUMiC prosthesis is a good solution for the
patients who require resection of the periacetabular
pelvic bone. The patients maintain walking ability
with the use of crutches and they experience
significant pain relief.
Abbreviations
PMMA: polymethyl methacrylate; PFE: proximal femur endoprosthesis;
VAS: Visual Analoque Scale.
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